Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASOPHARYNGEAL CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06675214
What this trial is testing

Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

Who this might be right for
Nasopharyngeal CarcinomaDe-escalation Therapy
Sun Yat-sen University 586
Testing effectiveness (Phase 2)Study completedNCT00305734
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent Nasopharyngeal CancerStage IV Nasopharyngeal Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06987123
What this trial is testing

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 62
Very early researchNot Yet RecruitingNCT06752473
What this trial is testing

KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)EBV
Kousai Bio Co., Ltd. 10
Testing effectiveness (Phase 2)Looking for participantsNCT07749586
What this trial is testing

Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Arvinas Inc. 499
Not applicableStudy completedNCT03989297
What this trial is testing

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Kiang Wu Hospital 104
Testing effectiveness (Phase 2)Study completedNCT02237924
What this trial is testing

Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University 120
Not applicableStudy completedNCT02113423
What this trial is testing

Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer Recurrent
Fujian Cancer Hospital 168
Testing effectiveness (Phase 2)Study completedNCT00006248
What this trial is testing

S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 78
Testing effectiveness (Phase 2)Study completedNCT01316757
What this trial is testing

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+20 more
Fox Chase Cancer Center 24
Not applicableStudy completedNCT05834712
What this trial is testing

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 224
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04925544
What this trial is testing

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Related Carcinoma
Stanford University 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03097939
What this trial is testing

Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 113
Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Large-scale testing (Phase 3)UnknownNCT01536223
What this trial is testing

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma

Who this might be right for
ChemoradiationNasopharyngeal Carcinoma
Zhejiang Cancer Hospital 400
Large-scale testing (Phase 3)Looking for participantsNCT06277050
What this trial is testing

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaHigh-Risk CancerMaintenance Therapy
Jiangxi Provincial Cancer Hospital 264
Testing effectiveness (Phase 2)Study completedNCT02444949
What this trial is testing

A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
China Three Gorges University, Yichang, China 75
Large-scale testing (Phase 3)Study completedNCT01528618
What this trial is testing

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 362
Next Page